An Unusual Cause of Primary Amenorrhea

    Nadiia Marenych, Sabah Patel, Janice L Gilden
    Image of study
    TLDR The 18-year-old girl likely has a condition called müllerian agenesis, which caused her to not have a uterus and experience no menstrual periods.
    An 18-year-old Vietnamese female with primary amenorrhea and normal pubertal development was referred to an endocrine clinic. Despite having a normal female phenotype and normal laboratory findings, a pelvic ultrasound at age 17 revealed the absence of a uterus, and oral contraceptives failed to induce withdrawal bleeding. Her family history showed no reported infertility, with her siblings experiencing menarche at typical ages. The patient declined karyotype testing, which left müllerian agenesis, 5-alpha-reductase deficiency, and complete androgen insensitivity syndrome as differential diagnoses. However, based on her clinical presentation, the most likely diagnosis was müllerian agenesis (Mayer-Rokitansky-Kuster-Hauser syndrome), a condition with an incidence of 1/4,500-5,000 females caused by embryologic underdevelopment of the müllerian duct. Psychosocial and genetic counseling, as well as discussions on options for pregnancy, are important for patients with this syndrome, who may also exhibit certain personality traits such as higher neuroticism, depression, and decreased coping styles.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 290 results

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  134 upvotes 8 months ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

      community We need to keep these snake oil companies accountable.

      in Treatment  119 upvotes 6 months ago
      Biotin is being misleadingly marketed as a primary treatment for androgenic alopecia, overshadowing more effective treatments like finasteride and minoxidil. There is a call for increased awareness and accountability to prevent misinformation.

      community I love Costco. Fin is less than $3 per month without insurance.

      in Finasteride/Dutasteride  128 upvotes 9 months ago
      The conversation discusses the affordability of finasteride for hair loss treatment, with users sharing that it can be obtained for less than $3 per month at Costco without insurance, and the cost can be further reduced by getting a year's prescription at once. Some users also mention getting prescriptions from their primary care physician or online services.

      community Minoxidil should not be underestimated

      in Minoxidil  196 upvotes 2 weeks ago
      Minoxidil can help with hair regrowth, especially when combined with finasteride, but it doesn't address the root cause of androgenic alopecia. Finasteride is often recommended as the primary treatment, with minoxidil as a supportive option.

    Similar Research

    5 / 1000+ results
      Current Evaluation of Amenorrhea

      research Current Evaluation of Amenorrhea

      30 citations, July 2004 in “Fertility and Sterility”
      Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.
      Current Evaluation of Amenorrhea

      research Current Evaluation of Amenorrhea

      21 citations, September 2004 in “Fertility and Sterility”
      Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.
      Current Evaluation of Amenorrhea

      research Current Evaluation of Amenorrhea

      38 citations, October 2006 in “Fertility and Sterility”
      The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.
      Current Evaluation of Amenorrhea

      research Current Evaluation of Amenorrhea

      78 citations, November 2008 in “Fertility and Sterility”
      Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.